medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2010, Número 4

Dermatología Cosmética, Médica y Quirúrgica 2010; 8 (4)


Síndrome de Sweet. Informe de un caso

Sáenz CC, Plascencia GA, de Anda JM, Gómez VR, Reyes MG, Karam OM, Vega ME

Idioma: Español
Referencias bibliográficas: 16
Paginas: 255-257
Archivo PDF: 664.92 Kb.


RESUMEN

Se presenta el caso de una paciente de 55 años diagnosticada con síndrome de Sweet, con placas eritematosas, urticariformes, bien delimitadas –algunas con costra central–, con lesiones tipo eritema nudoso e infiltrado neutrofílico en dermis.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Wallach D, Vignon-Pennamen M. “From acute febrile neutrophilic dermatosis to neutrophilic disease: Forty years of clinical research”. American Academy of Dermatology 2006; 55: 1066-1071.

  2. Chung VQ, Liu V, et al. “Clinical and pathologic findings of paraneoplastic dermatoses”. J Am Acad Dermatol 2006; 54: 745-762.

  3. Ratzinger G, Zelger B. “Acute febrile neutrophilic dermatosis: A histopathologic study of 31 cases with review of literature”. Am J Dermatopathol 2007; 29: 125-133.

  4. Hisanaga K, Iwasaki Y, the Neuro-Sweet Disease Study Group. “Neuro- Sweet disease, clinical manifestations and criteria for diagnosis”. Neurology 2005; 64: 1756-1761.

  5. Dyer JA, Mancini AJ. “Neutrophilic panniculitis in infancy: A cutaneous manifestation of juvenile rheumatoid arthritis”. American Academy of Dermatology 2007; 57: S65-S68.

  6. Yamauchi P, Turner L, Lowe NJ, Gindi V, Jackson M. “Treatment of recurrent Sweet’s syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept”. J Am Acad Dermatol 2006; 54(3 Suppl 2): S122-6.

  7. Teng J, Draper BK, Boyd A, et al. “Sweet’s panniculitis associated with metastatic breast cancer”. J Am Acad Dermatol 2007;56(2 Suppl):S61-2

  8. Guillaume M, Bourcier T, et al. “Sweet syndrome presenting as resistant conjunctivitis”. Cornea 2008; 27: 1189-1190.

  9. Spencer B, Nanavati A, Greene J, Butler D. “Dapsone-responsive histiocytoid Sweet’s syndrome associated with Crohns disease”. J Am Acad Dermatol 2008; 59 (2 Suppl 1): S58-60.

  10. Vergara F, Zuazaga L, Cabrera G, et. al. “Síndrome de Sweet. A propósito de un caso.” Séptimo Congreso Virtual Hispanoamericano de Anatomía Patológica. www.conganat.org. Enero de 2006.

  11. Hisashi H, Toshiro I, et. al. “Neutrophilic dermatoses with acute myeloid leukemia associated with an increased of serum colony-stimulating factor”. J Am Acad Dermatol 2008; 59: S10-S12.

  12. LeBoith P. “From Sweet to Miescher and back again”. Am J Dermatopathology 2006; 28: 381-383.

  13. Jagdeo J, Robinson-Bostom L. “Sweet’s Syndrome-like neutrophilic Lobular panniculitis associated with all-trans-retinoic acid chemotherapy in a patient with acute promyelocytic leukemia”. Am Acad Dermatology 2007; 690-693.

  14. Cholongitas E, Loukas K, et. al. “Piperacillin/Tazobactam-Induced Sweet Syndrome in a patient with chronic lymphocytic leukemia and autoimmune cholangitis”. Am J Dermatopathol 2008; 30 (2): 203-204.

  15. Alper Y, Sprecher E, Bergman R, Birnbaum RF. “Sweet’s Syndromelike neutrophilic dermatosis resulting from exposure to a radiocontrast agent”. J Am Acad Dermatol 2008; 58(3): 488-489.

  16. Bolognia JL. Dermatología. 1a edición, Elsevier, España, 2004; 411-415.




2020     |     www.medigraphic.com